http://hdl.handle.net/1765/34396
http://dx.doi.org/10.1586/erv.11.25
pubmed: 21506635
scopus: 79955113278
http://dx.doi.org/10.1586/erv.11.25
pubmed: 21506635
scopus: 79955113278
ISCOM technology-based Matrix M™ adjuvant: Success in future vaccines relies on formulation
April 2011
Article
volume 10, issue 4 pp 401-403.
Repository contains one file which is not publicly available
Keywords